(NASDAQ: GDRX) Goodrx Holdings's forecast annual revenue growth rate of 7.84% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 12.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Goodrx Holdings's revenue in 2024 is $764,159,000.On average, 9 Wall Street analysts forecast GDRX's revenue for 2024 to be $302,014,226,007, with the lowest GDRX revenue forecast at $300,317,923,696, and the highest GDRX revenue forecast at $304,936,698,625. On average, 9 Wall Street analysts forecast GDRX's revenue for 2025 to be $330,931,659,194, with the lowest GDRX revenue forecast at $317,108,352,458, and the highest GDRX revenue forecast at $348,865,713,138.
In 2026, GDRX is forecast to generate $359,523,039,139 in revenue, with the lowest revenue forecast at $331,414,923,378 and the highest revenue forecast at $377,043,617,049.